yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q52615236-14DE47C6-A685-4151-96C3-67BD8FED9E2C
Q52615236-14DE47C6-A685-4151-96C3-67BD8FED9E2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52615236-14DE47C6-A685-4151-96C3-67BD8FED9E2C
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
P2860
Q52615236-14DE47C6-A685-4151-96C3-67BD8FED9E2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52615236-14DE47C6-A685-4151-96C3-67BD8FED9E2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fee0155a35b0892314bee08acffe1cf27a54d232
P2860
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.